Company: OXBRW
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001641172-25-000736
Chunk: 124

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-03-26
Form: 10-K
Item: Item 14
Chunk 124
---
or other securities laws. The Securities were sold in a transaction exempt from registration under the Securities Act and were sold only
to persons reasonably believed to be accredited investors in the United States under SEC Rule 506(c) under the Securities Act and outside
the United States only to non-U.S. persons in accordance with Regulation S under the Securities Act.

    F-16

OXBRIDGE
RE HOLDINGS LIMITED AND SUBSIDIARIES 

Notes
to Consolidated Financial Statements, Continued

The
selected unconsolidated historical financial information and other data presented below is derived from SurancePlus’
standalone unaudited financial statements for years ended December 31, 2024 and 2023 and the balance sheet data as of December 31,
2024 and 2023.

 SCHEDULE OF FINANCIAL STATEMENTS

    For
    Year Ended 
     
    For Year Ended

    Statement of Operations Data: 
    December 31, 2024 
     
    December 31, 2023

    (Unaudited) 
     
    (Unaudited)

    (In thousands) 
     
    (In thousands)

    SurancePlus fee & investment income 
    $634 
     
    $
    574

    Underwriting-related income 
    $2,050 
     
    $
    1,140

    Total revenue 
    $2,684 
     
    $
    1,714

    Expenses 
    $(201)
     
    $
    (272
    )
  
    Income attributable to token holders 
    $(1,867)
     
    $
    (1,036
    )
  
    Net income 
    $616 
     
    $
    406

    Balance Sheet Data: 
    At
    December 31, 2024 
     
    At December 31, 2023

    (Unaudited) 
     
    (Unaudited)

    (In thousands) 
     
    (In thousands)

    Total assets 
    $4,794 
     
    $
    3,588

    Amounts due to EpsilonCat Re / DeltaCat Re tokenholders* 
    $2,284 
     
    $
    2,016

    Due to Parent 
    $40 
     
    $
    47

    Total shareholders’ equity 
    $2,470 
     
    $
    1,